Potassium permanganate poisoning 43 motor signs. For this reason we believe patients presenting with severe, unexplained shoulder girdle pain should be offered follow up, preferably by their general practitioner. If motor signs develop, the diagnosis can be confirmed with EMG and the patient reassured that the prognosis is excellent.
On arrival, she was alert and oriented. Her airway was patent and she had no stridor. There were brownish black stains on her hands and lips. There were similar staining of the entire oropharynx. The tongue and lips were swollen and bled on contact. Direct laryngoscopy under local anaesthesia showed a stained and oedematous pharynx, with gross swelling of the laryngeal structures. She was anaesthetised, intubated, and ventilated and was admitted to the intensive care unit.
Initial chest x ray was normal. Oesophagoscopy soon after admission showed staining of the upper oesophagus. The rest of the oesophagus, stomach, and duodenum were normal, The immediate concern after the ingestion of potassium permanganate is the threat of acute laryngeal oedema6 and this necessitates early endotracheal intubation or even emergency surgical airway. Although this patient did not have stridor at presentation, there was laryngeal oedema and this would probably have progressed to upper airway obstruction with time.
Manifestations of the gastrointestinal effects include nausea and vomiting in the mild cases. Burns and ulceration of the mouth, oesophagus, and stomach occur and are due to its caustic action. It combines with proteins to form proteinates and with fats to form soaps, resulting in necrotic ulcers which may continue to penetrate for days7 and may lead to perforation. Early oesophagoscopy is recommended to assess the severity of the oesophageal burns, although the manganese staining may obscure the area of the burn. Haemorrhagic pancreatitis has also been reported in a patient who ingested 20 g of potassium permanganate8 but this was not seen in our patient. Late complications of upper gastrointestinal ulceration include oesophageal stricture9 and pyloric stenosis.10 Hepatic and renal damage has been well documented and in one patient, liver damage occurred after self injection of potassium permanganate into the chest." Our unfortunate patient suffered both the hepatic and renal toxic effects of potassium permanganate.
Methaemoglobinaemia has been reported,12
although it did not occur in our patient. Cardiovascular depression and collapse with shock is another feature of severe potassium permanganate poisoning although the pathogenesis is uncertain and it is often the cause of death in those who do not succumb to the immediate threat of airway obstruction or massive haemorrhage due to gastrointestinal erosions.
The mainstay in the treatment of potassium permanganate is supportive. The immediate priority is to secure the airway. Although gastric lavage has been recommended by some,6 it is potentially hazardous7 as there is danger of perforation. The effectiveness of activated charcoal is not known in potassium permanganate poisoning and thus its administration is controversial. Drinking of milk or water may have a diluting and neutralising effect. 13 Early oesophagoscopy is useful to determine the extent of upper gastrointestinal injury. Useful investigations include liver and renal function tests, methaemoglobin level, serum amylase, and serum manganese. Other supportive treatment includes the administration of methylene blue and vitamin C for methaemoglobinaemia12 and broad spectrum antibiotics in view of the risk of perforation and subsequent peritonitis. The use of corticosteroids is controversial although it has been postulated that they minimised tissue oedema and the pathological inflammatory response in one patient. 13 Thus what appears to be a harmless topical agent can, when ingested in sufficient amounts, result in widespread systemic toxicity that can cause much morbidity and even mortality.
oxygen, an oropharyngeal airway was inserted, and intravenous fluids were given. The history obtained from her husband was of several hours vomiting before the fit, but no history of any febrile illness or upper respiratory tract symptoms. She had been epileptic for' 12 years, and despite taking vigabatrin (Sabril) and sodium valproate was poorly controlled. Of relevance in her past medical history was that she had suffered from an episode of pneumococcal meningitis before the start of her epilepsy.
On examination she was pyrexial (38.4°C) with a tachycardia of 130 beats/min. There was decreased air entry to the right lung base, consistent with aspiration, later confirmed by chest radiograph. Her Glasgow coma score was between 6 and 10. Further examination revealed no other abnormalities.
She was nursed in the recovery position. To reduce the risk of further aspiration the insertion of a nasogastric tube (NG) was Figure 1 Computerised tomography scan showing the intracranial placement of the nasogastric tube.
